Digestive & Intestinal Remedies (Pharmacies) - Czechia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$67.86m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.19%, resulting in a market volume of US$75.63m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$6.46 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Czechia is experiencing steady growth due to changing customer preferences and emerging trends in the market.

Customer preferences: Customers in Czechia are increasingly seeking digestive and intestinal remedies to address common digestive issues such as indigestion, heartburn, and bloating. This can be attributed to the changing lifestyle and dietary habits of the population, including the consumption of processed foods and irregular eating patterns. As a result, there is a growing demand for over-the-counter remedies that provide quick relief from these digestive discomforts.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Czechia is the shift towards natural and herbal remedies. Customers are becoming more conscious about the potential side effects of pharmaceutical drugs and are seeking natural alternatives to address their digestive issues. This trend is driven by the growing popularity of holistic health practices and the increasing availability of natural remedies in pharmacies and health stores. Another trend in the market is the rising demand for probiotics and prebiotics. These products are known to promote a healthy gut microbiome and improve digestion. Consumers are becoming more aware of the benefits of maintaining a healthy gut and are actively seeking products that support gut health. This trend is further supported by the growing body of scientific research highlighting the link between gut health and overall well-being.

Local special circumstances: Czechia has a well-developed healthcare system, which includes a network of pharmacies that offer a wide range of digestive and intestinal remedies. Pharmacies in Czechia are easily accessible to the population, with many operating extended hours and providing professional advice to customers. This accessibility and availability of remedies contribute to the growing demand in the market.

Underlying macroeconomic factors: The overall economic stability and increasing disposable income in Czechia are also contributing to the growth of the Digestive & Intestinal Remedies market. As individuals have more purchasing power, they are willing to invest in products that improve their digestive health and overall well-being. Additionally, the aging population in Czechia is driving the demand for digestive remedies, as older individuals are more prone to digestive issues and seek effective solutions. In conclusion, the Digestive & Intestinal Remedies market in Czechia is growing due to changing customer preferences towards natural and herbal remedies, the rising demand for probiotics and prebiotics, the accessibility of pharmacies, and the overall economic stability in the country. As these trends continue to evolve, the market is expected to witness further growth in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.